acetylsalicyclic acid (ASA)

Phase 3Small molecule

Bayer

acetylsalicyclic acid (ASA) is one of 12 small molecule programs targeting Cholesterol. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

CholesterolRecruiting

CholesterolPhase 3

Recruiting

Competition

Competitive Landscape

13 competitors in Cholesterol

#DrugCompanyPhaseTrials

Repatha

Amgen

Approved

5 2

Zetia

OOrganon and Co

Approved

16 3

Crestor

AstraZeneca

Approved

4 4

Plavix

Sanofi

Phase 3

1 5

Lipitor

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

6 6

Atorvastatin Calcium

Merck & Co.

Phase 3

1 7

Propolis

IIndonesia University

Phase 3

1 8

Cortrosyn

Novartis

Phase 1

1 9

Decadron

AAspen Global Incorporated

Phase 1

1 10

acetylsalicyclic acid (ASA)

Bayer

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2040

Phase 3Recruiting

Cholesterol

NCT07012629

Clinical

Trials by Indication[1]

Analgesic Efficacy1 trial

Evaluate Analgesic Efficacy of Fast Release Aspirin

Completed· Bayer logo

Bayer·Phase 3·NCT01122602·500 enrolled

Aspirin1 trial

Evaluate Onset of Action of a Fast Release Aspirin

Completed· Bayer logo

Bayer·Phase 3·NCT01420094·510 enrolled

Cholesterol1 trial

A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

Recruiting·—·Phase 3·NCT07012629·1,652 enrolled

Antiplatelet1 trial

Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS

Completed· Sanofi logo

Sanofi·Phase 3·NCT00335452·25,086 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for acetylsalicyclic acid (ASA). U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — acetylsalicyclic acid (ASA) compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for acetylsalicyclic acid (ASA). EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Bayer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Bayer

acetylsalicyclic acid (ASA)

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2040

Trials by Indication[1]

Analgesic Efficacy1 trial

Aspirin1 trial

Cholesterol1 trial

Antiplatelet1 trial

References

Drug Info

Quick Facts

Related News